| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 04/17/1996 | EP0706575A1 Retroviral vectors for transducing beta-globin gene and beta-locus control region derivatives |
| 04/17/1996 | EP0706574A1 Methods for peptide synthesis and purification |
| 04/17/1996 | EP0706571A1 Tuberculosis vaccine |
| 04/17/1996 | EP0706570A1 Plants having modified response to ethylene |
| 04/17/1996 | EP0706568A1 Vertebrate apoptosis gene: compositions and methods |
| 04/17/1996 | EP0706567A1 Peptide family, designated as xenonins |
| 04/17/1996 | EP0706566A1 Conotoxins having acetylcholin receptor binding properties |
| 04/17/1996 | EP0706565A1 A synthetic gene for d4 dopamine receptors |
| 04/17/1996 | EP0706564A1 Protein s deletion variants deficient in c4bp binding activity, but having apc cofactor activity, compositions and therapeutic methods |
| 04/17/1996 | EP0706563A1 A truncated keratinocyte growth factor (kgf) having increased biological activity |
| 04/17/1996 | EP0706562A1 Culture medium for recombinant yeasts |
| 04/17/1996 | EP0706533A1 Synthetic peptides of human papillomavirus |
| 04/17/1996 | EP0706319A1 Retroviral vectors capable of expressing multimeric proteins from multiple translational initiation sites |
| 04/17/1996 | EP0651822B1 Diagnostic method |
| 04/17/1996 | EP0638091A4 Improved solubilization and stabilization of factor viii complex. |
| 04/17/1996 | EP0598029A4 Retroviral vectors containing internal ribosome entry sites. |
| 04/17/1996 | EP0568594B1 NOVEL INSULIN ANALOGS suited for transdermal application |
| 04/17/1996 | EP0539523B1 Beta chain of the human gm-csf receptor and uses thereof |
| 04/17/1996 | EP0506826B1 Antibody antagonists of human interleukin-4 |
| 04/17/1996 | EP0436660B1 Peptides and antibodies that inhibit integrin-ligand binding |
| 04/17/1996 | EP0428596B1 Novel infectious bursal disease virus |
| 04/17/1996 | EP0424519B1 Antigenes of the envelope transmembrane glycoprotein of a human retrovirus of the hiv-2 type, and antigens presenting with them an immunological relationship |
| 04/17/1996 | EP0414808B1 PROCESS FOR SCREENING AN EXPRESSION cDNA CLONE BANK FOR POLYNUCLEOTIDES |
| 04/17/1996 | EP0401271B1 Antigen against diabetes |
| 04/17/1996 | EP0290565B1 Vaccine containing tick antigens |
| 04/17/1996 | CN1120846A Metal-interferon-alpha crystals |
| 04/17/1996 | CN1120549A Calcitonin analogue and use thereof |
| 04/17/1996 | CN1120547A Method for prepn. of NTPS |
| 04/17/1996 | CN1120456A "Cunaokang" medicine for promoting brain health |
| 04/17/1996 | CN1120439A Low temperature albumin fractionation using sodium caprylates as a partitioning agent |
| 04/17/1996 | CN1120396A Process for the preparation of protein-rich product from brewer's spent grain |
| 04/16/1996 | US5508468 Genetic engineering; particle bombardment |
| 04/16/1996 | US5508437 Appetite suppressants |
| 04/16/1996 | US5508386 An immunoglobulin molecule containing a tetrapeptide epitope within the third complementarity-determining region in the n-terminus variable domain thereof |
| 04/16/1996 | US5508385 Protease inhibitor; antiulcer agents, antiinflammatory agents; treating pancreatitis |
| 04/16/1996 | US5508384 Polypeptide derived from a popamine receptor, and compositions and methods thereof |
| 04/16/1996 | US5508382 Synthetic calcitonin |
| 04/16/1996 | US5508291 Treatment of feline vital disease; antitumor agents |
| 04/16/1996 | US5508265 Administering to prevent accumulation of excess, extracellular free actin and to inhibit secondary tissue injury |
| 04/16/1996 | US5508264 Synergistic combinations of a cryif chimeric and cryia(c) chimeric bacillus thuringiensis delta-endotoxin; for controlling lepidopteran pests |
| 04/16/1996 | US5508263 A solid matrix having a protein coatings prepared from culturing two different nucleotide sequences; repairing bone defects |
| 04/16/1996 | US5508262 Interleukin-1 receptor antagonist decreases severity of acute pancreatitis |
| 04/16/1996 | US5508261 Analogs of glycoprotein hormones having altered receptor binding specificity and activity and methods for preparing and using same |
| 04/16/1996 | US5508186 Has vp1 minor structural protein to vp2 major structural protein ratio higher than the ratio of naturally occurring full capsid |
| 04/16/1996 | US5508177 Lysing, fractionating, contacting with ion exchange resins, eluting, diluting, contacting with dye-ligand resin, eluting from dye-ligand resin |
| 04/16/1996 | US5508176 Allows preparation of mutarotase in genetic engineering process in high yields |
| 04/16/1996 | US5508170 Liquid thromboplastin reagent |
| 04/16/1996 | US5508167 Detecting presence or absence of an apolipoprotein e type 4 isoform(apoe4) in subject by immunoassay |
| 04/16/1996 | US5508032 Bacillus thuringiensis isolates active against cockroaches |
| 04/16/1996 | US5508020 Technetium-99M labeled peptides for imaging |
| 04/15/1996 | CA2160529A1 Bacillus strain and harmful organism controlling agents |
| 04/14/1996 | CA2160449A1 Galanin receptor protein, production and use thereof |
| 04/11/1996 | WO1996010746A1 Methods of identifying agents which block hiv infection |
| 04/11/1996 | WO1996010649A1 Isolated human hepatitis b virus polymerase and uses thereof |
| 04/11/1996 | WO1996010642A1 Adenovirus-derived viral vectors having two therapeutic genes: suicide and immunopotentiating |
| 04/11/1996 | WO1996010639A2 THE tagA GENE AND METHODS FOR DETECTING PREDISPOSITION TO PEPTIC ULCERATION AND GASTRIC CARCINOMA |
| 04/11/1996 | WO1996010638A1 Alpha-1-antitrypsin and antithrombine-iii variants |
| 04/11/1996 | WO1996010637A1 Human alpha4 receptor subunit of the gaba-a receptor |
| 04/11/1996 | WO1996010636A1 Novel compounds useful for preparing anti-infective agents |
| 04/11/1996 | WO1996010635A2 Genes encoding signal recognition particle of aspergillus niger |
| 04/11/1996 | WO1996010634A1 Inhibitor of stem cell proliferation and uses thereof |
| 04/11/1996 | WO1996010633A1 Chimeric influenza virus and electroporation method |
| 04/11/1996 | WO1996010632A1 Recombinant negative strand rna virus expression systems and vaccines |
| 04/11/1996 | WO1996010631A1 Nucleic acid encoding mutant matrix proteins useful for attenuation or enhancement of influenza a virus |
| 04/11/1996 | WO1996010630A1 Direct introduction of foreign materials into cells |
| 04/11/1996 | WO1996010629A1 The irs family of genes |
| 04/11/1996 | WO1996010628A1 Endothelial cell-specific enhancer |
| 04/11/1996 | WO1996010584A1 Process for extracting high-purity von willebrand factor |
| 04/11/1996 | WO1996010583A1 Vaccine containing a haemoprotein |
| 04/11/1996 | WO1996010582A1 Crosslinking processes/agents for zein |
| 04/11/1996 | WO1996010580A2 Recombinant proteins of a pakistani strain of hepatitis e and their use in diagnostic methods and vaccines |
| 04/11/1996 | WO1996010579A1 Blocking expression of virulence factors in s. aureus |
| 04/11/1996 | WO1996010578A1 Novel protein marker and dna encoding same |
| 04/11/1996 | WO1996010577A1 Isolated nucleic acid molecule coding for tumor rejection antigen precursor dage and uses thereof |
| 04/11/1996 | WO1996010576A1 HIGH-AFFINITY OLIGONUCLEOTIDE LIGANDS TO IMMUNOGLOBULIN E (IgE) |
| 04/11/1996 | WO1996010427A2 Cellular attachment to trans-epithelial appliances |
| 04/11/1996 | WO1996010424A1 Cellular immunity-inducing conjugate |
| 04/11/1996 | WO1996010423A1 COMPOSITIONS CONTAINING A p53 DERIVED PROTEIN OR PEPTIDE, AN ADJUVANT, AND INTERLEUKIN-12 AND USES THEREOF |
| 04/11/1996 | WO1996010419A2 Composition comprising a recombinant virus expressing an antigen and a recombinant virus expressing an immunostimulatory molecule |
| 04/11/1996 | WO1996010418A1 Human monocyte elastase inhibitor |
| 04/11/1996 | WO1996010415A1 Preparation of mhc-peptide complexes |
| 04/11/1996 | WO1996010414A1 Trophinin and trophinin-assisting proteins |
| 04/11/1996 | WO1996010413A1 Compositions containing tumor rejection antigen precursors or tumor rejection antigens, and an adjuvant and/or growth factor |
| 04/11/1996 | WO1996010411A1 Immunotherapeutic stress protein-peptide complexes against cancer |
| 04/11/1996 | WO1996010401A1 Methods for regulation of insulin-like growth factor i receptor |
| 04/11/1996 | WO1996010400A1 Gene therapy vectors and vaccines based on non-segmented negatives stranded rna viruses |
| 04/11/1996 | WO1996006171A3 New polypetides having a toxic activity against insects of the dipterae family |
| 04/11/1996 | WO1996005866A3 Live vaccine for the treatment of tumour diseases |
| 04/11/1996 | DE4436164A1 New conjugates of tetra:carbohydrate and amide-linked peptide or dye etc. |
| 04/11/1996 | DE4435907A1 Recombinant papilloma virus-like particles contg. L1 or L2 proteins |
| 04/11/1996 | CA2201748A1 Genes encoding signal recognition particle of aspergillus niger |
| 04/11/1996 | CA2201588A1 Recombinant proteins of a pakistani strain of hepatitis e and their use in diagnostic methods and vaccines |
| 04/11/1996 | CA2201519A1 Preparation of mhc-peptide complexes |
| 04/11/1996 | CA2201506A1 Novel protein marker and dna encoding same |
| 04/11/1996 | CA2201498A1 Immunotherapeutic stress protein-peptide complexes against cancer |
| 04/11/1996 | CA2201474A1 The irs family of genes |
| 04/11/1996 | CA2201353A1 The taga gene and methods for detecting predisposition to peptic ulceration and gastric carcinoma |
| 04/11/1996 | CA2201327A1 Compositions containing tumor rejection antigen precursors or tumor rejection antigens, and an adjuvant and/or growth factor |
| 04/11/1996 | CA2201315A1 Direct introduction of foreign materials into cells |
| 04/11/1996 | CA2201281A1 Human alpha 4 receptor subunit of the gaba-a receptor |